MENU
NGNE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Neurogene (NGNE) Ownership - Who owns Neurogene?

Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACT(Expression Attenuation via Construct Tuning)... Show more

Profile

Industry
N/A
Address
535 W 24th Street
Phone
+1 855 508-3568
Employees
131
Web
https://www.neurogene.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
508.82M
P/E Ratio
N/A
Total Cash
243.18M
Projected Growth
N/A
Total Debt
9.54M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
15.39
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
NGNE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
535 W 24th Street
Phone
+1 855 508-3568
Employees
131
Web
https://www.neurogene.com